What changed
$MOH — AVOID 📊
Molina Healthcare, Inc.
🎯 Q2 2026 | Rev $11B | EPS $2.35 vs $1.91 🟢
💡 The market likely extrapolated the Q1 beat into a full-year guidance raise, but the unchanged FY outlook signals caution or one-off strength. Consensus may be overestimating sustainable earnings power, while the rich multiple leaves no room for disappointment.
📉 Reward/risk: 0.87:1
🏢 Business Quality: 7/10
📊 Valuation: rich
🔮 Catalyst: None in the next 3 months that would drive further re-rating; Q2 earnings (likely July/August) could serve as a negative catalyst if expectations are not met.
💰 Entry: $201.42, stop $180.0, target $220.0
⚖️ Avoid MOH at $201.42; the rich valuation and lack of near-term catalysts limit upside while exposing to downside risk. Wait for a pullback to $150 or a guidance raise before considering a long.
📊 Our read: AVOID. Full analysis →
https://stockduty.xyz/s/MOH0625